Healthcare companies by risk reading
Healthcare companies by risk reading: 1,695 companies ranked by a composite risk reading built from filed statements -- leverage, cash conversion, operating pressure, customer and supplier concentration and competitive position. Recomputed 21 October 2026.
Composite readings for 14,899 companies, recomputed 21 October 2026. A company appears here once at least three weighted categories cleared their inputs; the rest carry per-mechanism readings without a headline.
| Company | Reading | Band | Sector | Country | Coverage | Market cap |
|---|---|---|---|---|---|---|
| Xlife Sciences AG XLS.SW | 94 | Acute | Healthcare | Switzerland | 5 / 6 | $69M |
| Lumos Diagnostics Holdings Ltd LDX | 80 | Acute | Healthcare | United States | 3 / 6 | $68M |
| Heron Therapeutics Inc HRTX | 48 | Elevated | Healthcare | United States | 5 / 6 | $68M |
| Ondine Biomedical Inc OBI | 53 | Elevated | Healthcare | Canada | 5 / 6 | $68M |
| Forian Inc FORA | 28 | Normal | Healthcare | United States | 4 / 6 | $68M |
| NeOnc Technologies Holdings Inc NTHI | 67 | Stretched | Healthcare | United States | 4 / 6 | $68M |
| GENOVA, Inc. 9341.T | 34 | Normal | Healthcare | Japan | 5 / 6 | $68M |
| HealthyWay Inc. 2587.HK | 32 | Normal | Healthcare | China | 5 / 6 | $67M |
| Wakamoto Pharmaceutical Co.,Ltd. 4512.T | 32 | Normal | Healthcare | Japan | 5 / 6 | $67M |
| Zentek Ltd ZTEK | 62 | Stretched | Healthcare | Canada | 5 / 6 | $66M |
| J Frontier Co.,Ltd. 2934.T | 33 | Normal | Healthcare | Japan | 5 / 6 | $66M |
| XLS XLS | 94 | Acute | Healthcare | Switzerland | 5 / 6 | $65M |
| Champions Oncology Inc CSBR | 47 | Elevated | Healthcare | United States | 6 / 6 | $65M |
| Spero Therapeutics Inc SPRO | 18 | Contained | Healthcare | United States | 5 / 6 | $65M |
| Austco Healthcare Ltd AHC | 19 | Contained | Healthcare | Australia | 3 / 6 | $65M |
| Shield Therapeutics plc STX.L | 50 | Elevated | Healthcare | United Kingdom | 5 / 6 | $64M |
| Kubota Pharmaceutical Holdings Co., Ltd. 4596.T | 43 | Elevated | Healthcare | Japan | 5 / 6 | $64M |
| China Biotech Services Holdings Limited 8037.HK | 84 | Acute | Healthcare | Hong Kong | 5 / 6 | $63M |
| Kato (Hong Kong) Holdings Limited 2189.HK | 37 | Normal | Healthcare | Hong Kong | 5 / 6 | $63M |
| Pomdoctor Ltd POM | 76 | Stretched | Healthcare | China | 4 / 6 | $63M |
| Fortress Biotech Inc FBIO | 83 | Acute | Healthcare | United States | 4 / 6 | $62M |
| MindWalk Holdings Corp HYFT | 57 | Elevated | Healthcare | United States | 5 / 6 | $62M |
| Immuno-Biological Laboratories Co., Ltd. 4570.T | 26 | Normal | Healthcare | Japan | 5 / 6 | $62M |
| Gallmetzer HealthCare SPA GHC.VI | 75 | Stretched | Healthcare | Italy | 3 / 6 | $61M |
| Creo Medical Group PLC CREO | 75 | Stretched | Healthcare | United Kingdom | 5 / 6 | $61M |
| Vincent Medical Holdings Limited 1612.HK | 26 | Normal | Healthcare | Hong Kong | 5 / 6 | $61M |
| Cardiff Oncology Inc CRDF | 53 | Elevated | Healthcare | United States | 4 / 6 | $61M |
| AnGes Inc AJW | 40 | Elevated | Healthcare | Japan | 5 / 6 | $61M |
| Venus Medtech (Hangzhou) Inc. 2500.HK | 67 | Stretched | Healthcare | China | 5 / 6 | $60M |
| MedSci Healthcare Holdings Limited 2415.HK | 46 | Elevated | Healthcare | China | 5 / 6 | $59M |
| Verrica Pharmaceuticals Inc VRCA | 42 | Elevated | Healthcare | United States | 5 / 6 | $59M |
| Hospital Corporation of China Limited 3869.HK | 33 | Normal | Healthcare | China | 5 / 6 | $59M |
| OSE Pharma SA OSE | 84 | Acute | Healthcare | France | 5 / 6 | $59M |
| DocCheck AG AJ91 | 36 | Normal | Healthcare | Germany | 5 / 6 | $59M |
| Biosino Bio-Technology and Science Incorporation 8247.HK | 86 | Acute | Healthcare | China | 5 / 6 | $58M |
| Pangaea Oncology, S.A. PANG.MC | 52 | Elevated | Healthcare | Spain | 5 / 6 | $58M |
| Morishita Jintan Co., Ltd. 4524.T | 36 | Normal | Healthcare | Japan | 5 / 6 | $58M |
| Yamashita Health Care Holdings,Inc. 9265.T | 41 | Elevated | Healthcare | Japan | 4 / 6 | $57M |
| Data Horizon Co.,Ltd. 3628.T | 40 | Elevated | Healthcare | Japan | 4 / 6 | $57M |
| AB SCIENCE AB.PA | 45 | Elevated | Healthcare | France | 5 / 6 | $57M |
| Labiana Health, S.A. LAB.MC | 34 | Normal | Healthcare | Spain | 5 / 6 | $57M |
| Connect Biopharma Holdings Ltd CNTB | 64 | Stretched | Healthcare | United States | 5 / 6 | $57M |
| Create Medic Co., Ltd. 5187.T | 29 | Normal | Healthcare | Japan | 5 / 6 | $56M |
| Adocia ADOC | 87 | Acute | Healthcare | France | 5 / 6 | $56M |
| FERMENTALG ALGAE.PA | 52 | Elevated | Healthcare | France | 5 / 6 | $56M |
| hVIVO plc HVO | 61 | Stretched | Healthcare | United Kingdom | 5 / 6 | $56M |
| THERACLION ALTHE.PA | 73 | Stretched | Healthcare | France | 4 / 6 | $56M |
| Beijing Health (Holdings) Limited 2389.HK | 60 | Stretched | Healthcare | Hong Kong | 5 / 6 | $55M |
| Xilio Therapeutics Inc XLO | 47 | Elevated | Healthcare | United States | 5 / 6 | $55M |
| Bactiguard Holding AB (publ) BACTI-B | 26 | Normal | Healthcare | Sweden | 4 / 6 | $55M |
| Koken Ltd. 7963.T | 35 | Normal | Healthcare | Japan | 5 / 6 | $55M |
| Mental Health Technologies Co.,Ltd. 9218.T | 15 | Contained | Healthcare | Japan | 5 / 6 | $54M |
| Theradiag SA ALTHE | 73 | Stretched | Healthcare | France | 4 / 6 | $54M |
| Medtecs International Corporation Limited 546.SI | 32 | Normal | Healthcare | Taiwan | 5 / 6 | $54M |
| Sequana Medical NV SEQUA | 93 | Acute | Healthcare | Belgium | 5 / 6 | $54M |
| Wai Yuen Tong Medicine Holdings Limited 0897.HK | 40 | Elevated | Healthcare | Hong Kong | 5 / 6 | $53M |
| One Health Group Plc OHGR | 21 | Normal | Healthcare | United Kingdom | 5 / 6 | $53M |
| Pheton Holdings Ltd - Class A ITOC | 68 | Stretched | Healthcare | China | 4 / 6 | $53M |
| ALGAE ALGAE | 52 | Elevated | Healthcare | France | 5 / 6 | $53M |
| RenovoRx Inc RNXT | 46 | Elevated | Healthcare | United States | 6 / 6 | $52M |
| Renalytix Plc RENX.L | 72 | Stretched | Healthcare | United Kingdom | 4 / 6 | $52M |
| Gossamer Bio Inc GOSS | 78 | Stretched | Healthcare | United States | 3 / 6 | $52M |
| CellSeed Inc. 7776.T | 75 | Stretched | Healthcare | Japan | 5 / 6 | $51M |
| Uni-Bio Science Group Limited 0690.HK | 33 | Normal | Healthcare | Hong Kong | 5 / 6 | $51M |
| Advantage Risk Management Co., Ltd. 8769.T | 21 | Normal | Healthcare | Japan | 5 / 6 | $51M |
| EDX Medical Group Plc EDX.L | 48 | Elevated | Healthcare | United Kingdom | 4 / 6 | $51M |
| Envoy Medical Inc - Class A COCH | 71 | Stretched | Healthcare | United States | 5 / 6 | $50M |
| ASO International, Inc. 9340.T | 31 | Normal | Healthcare | Japan | 3 / 6 | $50M |
| Myomo Inc MYO | 57 | Elevated | Healthcare | United States | 5 / 6 | $49M |
| Kidswell Bio Corporation 4584.T | 42 | Elevated | Healthcare | Japan | 5 / 6 | $49M |
| Caribou Biosciences Inc CRBU | 65 | Stretched | Healthcare | United States | 6 / 6 | $49M |
| Spectral AI Inc - Class A MDAI | 83 | Acute | Healthcare | United States | 5 / 6 | $49M |
| Green International Holdings Limited 2700.HK | 33 | Normal | Healthcare | Hong Kong | 5 / 6 | $49M |
| Apollomics Inc - Class A APLM | 65 | Stretched | Healthcare | United States | 3 / 6 | $48M |
| NanoCarrier Co. Ltd 3NQ | 58 | Elevated | Healthcare | Japan | 4 / 6 | $48M |
| BATM Advanced Communications Ltd. BVC.L | 56 | Elevated | Healthcare | Israel | 5 / 6 | $48M |
| Mereo Biopharma Group Plc MREO | 67 | Stretched | Healthcare | United Kingdom | 3 / 6 | $48M |
| S H L Telemedicine Ltd SHLTN | 57 | Elevated | Healthcare | Israel | 5 / 6 | $48M |
| Orexo AB ORX | 96 | Acute | Healthcare | Sweden | 3 / 6 | $48M |
| KLEA HOLDING ALKLH | 16 | Contained | Healthcare | France | 5 / 6 | $47M |
| Nano Holdings, Inc. 4571.T | 56 | Elevated | Healthcare | Japan | 4 / 6 | $47M |
| Precision Optics Corp Inc POCI | 66 | Stretched | Healthcare | United States | 5 / 6 | $47M |
| Solasia Pharma K.K. 4597.T | 50 | Elevated | Healthcare | Japan | 3 / 6 | $47M |
| OncoTherapy Science, Inc. 4564.T | 68 | Stretched | Healthcare | Japan | 3 / 6 | $47M |
| Chiome Bioscience Inc. 4583.T | 61 | Stretched | Healthcare | Japan | 5 / 6 | $46M |
| StemCell Institute Inc. 7096.T | 36 | Normal | Healthcare | Japan | 5 / 6 | $46M |
| Suzhou Basecare Medical Corporation Limited 2170.HK | 54 | Elevated | Healthcare | China | 5 / 6 | $46M |
| SVAS BIOSANA SVS.MI | 32 | Normal | Healthcare | Italy | 5 / 6 | $46M |
| ONCOINVENT ONCIN.OL | 43 | Elevated | Healthcare | Norway | 5 / 6 | $46M |
| TALEA TALEA.MI | 33 | Normal | Healthcare | Italy | 5 / 6 | $46M |
| Sensus Healthcare Inc SRTS | 66 | Stretched | Healthcare | United States | 5 / 6 | $45M |
| Ikena Oncology Inc IMA | 67 | Stretched | Healthcare | United States | 4 / 6 | $45M |
| Cosmo Bio Company,Limited 3386.T | 27 | Normal | Healthcare | Japan | 5 / 6 | $45M |
| Carna Biosciences, Inc. 4572.T | 88 | Acute | Healthcare | Japan | 5 / 6 | $45M |
| UCHIYAMA HOLDINGS Co.,Ltd. 6059.T | 29 | Normal | Healthcare | Japan | 5 / 6 | $45M |
| MeVis Medical Solutions AG M3V | 39 | Normal | Healthcare | Germany | 4 / 6 | $45M |
| Oncoinvent ASA ONCIN | 43 | Elevated | Healthcare | Norway | 5 / 6 | $45M |
| Austar Lifesciences Limited 6118.HK | 45 | Elevated | Healthcare | China | 5 / 6 | $44M |
| HC Surgical Specialists Limited 1B1.SI | 28 | Normal | Healthcare | Singapore | 5 / 6 | $44M |
| Eyenovia Inc HYPD | 78 | Stretched | Healthcare | United States | 4 / 6 | $44M |
By sector
Industrials 3,117Technology 2,425Consumer Cyclical 2,231Healthcare 1,695Consumer Defensive 1,055Basic Materials 1,055Real Estate 1,011Communication Services 956Energy 487Utilities 343Financial Services 90
How the reading is built
Each company is scored on six mechanisms -- market expectation, operating pressure, cash conversion, leverage, concentration and competitive position -- from its own filed statements. A mechanism whose inputs do not clear its coverage floor is left unread rather than scored zero, and a reading built on thin coverage is pulled toward a neutral prior rather than claiming safety from what nobody looked at.
Descriptive, not advisory. These bands describe measured mechanisms; they are not investment advice, not a forecast, and not a statement about whether a share is worth owning.